Home Healthcare Healthcare Services Cell and Gene Therapy Manufacturing QC Market

Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR2172DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
  7. North America Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. U.S.
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Canada
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  8. Europe Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. U.K.
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Germany
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. France
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. Spain
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Italy
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Russia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    15. Nordic
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    16. Benelux
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    17. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  9. APAC Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. China
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Korea
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. Japan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. India
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Australia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  10. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. UAE
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Turkey
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. South Africa
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Egypt
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Nigeria
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    15. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  11. LATAM Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. Brazil
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Mexico
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. Argentina
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. Chile
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Colombia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022-2034 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022-2034 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022-2034 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022-2034 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  12. Competitive Landscape
    1. Cell and Gene Therapy Manufacturing QC Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. WuXi AppTec
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Lonza
    3. Thermo Fisher Scientific
    4. Charles River Laboratories
    5. Catalent
    6. Merck KGaA
    7. Eurofins Scientific
    8. Pace
    9. Pharmaron
    10. BioAgilytix Labs
    11. Avance Biosciences
    12. SGS
    13. IQVIA
    14. Alcami Corporation
    15. Solvias
    16. Pacific BioLabs
    17. ProtaGene
    18. Laboratory Corporation of America Holdings
    19. AGC Biologics
    20. uBriGene Biosciences International Co.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.